AMD Commits 10 Billion to Taiwans AI and Semiconductor Ecosystem to Bolster Chip Manufacturing LIC Increases Stake in Central Bank of India to 606 Jardine Matheson Acquires Australian Imaging Firm IMED in 31 Billion Deal HALO Stocks Emerge as a Compelling Investment Theme in the AI Era Toronto Blue Jays Legend Passes at Age Age Unknown from Source Lowes Signals Caution as Consumer Spending Patterns Shift UL Solutions Inc Q1 2026 Earnings Strong EPS Beat Drives Modest Share Gain ELS Q1 2026 Earnings Modest EPS Beat and Steady Market Response Magnite MGNI Q1 2026 Earnings EPS Beats Expectations as AdTech Momentum Continues HDSN Q1 2026 Earnings EPS Falls Sharply Below Estimates Stock Declines CHRW Q1 2026 Earnings EPS Beats Estimates Shares Rise 21 Oxford Lane Capital Corp Preferred Stock Shares 600 Series 2029 OXLCO Q4 2025 Earnings EPS Misses Estimates Despite Solid Operating Results RF Acquisition Corp II Rights RFAIR Hold Steady at 010 Amid Low Trading Activity AptarGroup ATR Edges Higher as Support Holds Testing Resistance Pixelworks PXLW Surges 346 Key Levels and Market Dynamics BioXcel Therapeutics BTAI Falls Further as Biotech Struggles to Hold Support TrioTech International TRT Plunges 14 Key Support Levels in Focus Workday Shares Rise on Improved Margin Forecast AIDriven Growth MGTX Q1 2026 Earnings Missed EPS Estimates as PreRevenue Biotech Advances Pipeline Corbus Pharmaceuticals CRBP Slides 14 as Key Support Level Comes into Focus Greene County Bancorp Inc GCBC Q2 2025 Earnings Solid EPS Performance Amidst Quiet Quarter NexPoint Real Estate Finance Inc Q1 2026 Earnings EPS Surpasses Estimates by 129 Stock Declines Embecta Corp EMBC Q1 2026 Earnings EPS Misses Estimates as Revenue Remains Undisclosed Brighthouse Financial Q1 2026 Earnings Insurance Giant Misses EPS Estimates Amid Market Volatility Gartner Q1 2026 Earnings EPS Surges Past Estimates Driving Positive Market Response SBAC Q1 2026 Earnings EPS Misses Estimates Amid Challenging Leasing Environment XENE Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Pipeline Advances